Key Sessions
Mark Cobbold
Strategies to Overcome Limitations of Cell Therapies in Cancer Treatment
AstraZeneca
Timothy Nelson, MD, PhD
TRACK KEYNOTE: The Case for Development of Autologous IPS-derived Cardiac Cells for Congenital Heart Disease
HeartWorks